DTIL
Price
$4.56
Change
-$0.15 (-3.18%)
Updated
Apr 4, 04:26 PM (EDT)
Capitalization
49.16M
IMNN
Price
$0.97
Change
-$0.03 (-3.00%)
Updated
Apr 4, 02:21 PM (EDT)
Capitalization
14.62M
45 days until earnings call
Ad is loading...

DTIL vs IMNN

Header iconDTIL vs IMNN Comparison
Open Charts DTIL vs IMNNBanner chart's image
Precision BioSciences
Price$4.56
Change-$0.15 (-3.18%)
Volume$200
Capitalization49.16M
Imunon
Price$0.97
Change-$0.03 (-3.00%)
Volume$100
Capitalization14.62M
DTIL vs IMNN Comparison Chart
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. IMNN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and IMNN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DTIL: $4.71 vs. IMNN: $1.00)
Brand notoriety: DTIL and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 63% vs. IMNN: 56%
Market capitalization -- DTIL: $49.16M vs. IMNN: $14.62M
DTIL [@Biotechnology] is valued at $49.16M. IMNN’s [@Biotechnology] market capitalization is $14.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 3 TA indicator(s) are bullish while IMNN’s TA Score has 6 bullish TA indicator(s).

  • DTIL’s TA Score: 3 bullish, 6 bearish.
  • IMNN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IMNN is a better buy in the short-term than DTIL.

Price Growth

DTIL (@Biotechnology) experienced а +3.74% price change this week, while IMNN (@Biotechnology) price change was -12.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.98%. For the same industry, the average monthly price growth was -16.85%, and the average quarterly price growth was -18.51%.

Reported Earning Dates

DTIL is expected to report earnings on May 13, 2024.

IMNN is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-10.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DTIL($49.2M) has a higher market cap than IMNN($14.6M). DTIL YTD gains are higher at: 23.622 vs. IMNN (5.263). DTIL has higher annual earnings (EBITDA): 18.8M vs. IMNN (-17.9M). DTIL has more cash in the bank: 101M vs. IMNN (5.87M). IMNN has less debt than DTIL: IMNN (1.14M) vs DTIL (30.3M). DTIL has higher revenues than IMNN: DTIL (75.1M) vs IMNN (0).
DTILIMNNDTIL / IMNN
Capitalization49.2M14.6M337%
EBITDA18.8M-17.9M-105%
Gain YTD23.6225.263449%
P/E Ratio4.51N/A-
Revenue75.1M0-
Total Cash101M5.87M1,720%
Total Debt30.3M1.14M2,660%
FUNDAMENTALS RATINGS
DTIL vs IMNN: Fundamental Ratings
DTIL
IMNN
OUTLOOK RATING
1..100
223
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
47100
PRICE GROWTH RATING
1..100
8549
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (36) in the Biotechnology industry is in the same range as IMNN (62) in the Medical Specialties industry. This means that DTIL’s stock grew similarly to IMNN’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that DTIL’s stock grew similarly to IMNN’s over the last 12 months.

DTIL's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for IMNN (100) in the Medical Specialties industry. This means that DTIL’s stock grew somewhat faster than IMNN’s over the last 12 months.

IMNN's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for DTIL (85) in the Biotechnology industry. This means that IMNN’s stock grew somewhat faster than DTIL’s over the last 12 months.

IMNN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as DTIL (100) in the Biotechnology industry. This means that IMNN’s stock grew similarly to DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILIMNN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPL34.720.10
+0.29%
Simply Good Foods Company (The)
IMAX25.73-0.85
-3.20%
Imax Corp
BKSY7.31-0.75
-9.31%
BlackSky Technology Inc
ADN3.10-0.41
-11.68%
Advent Technologies Holdings Inc.
WSM138.86-26.15
-15.85%
Williams-Sonoma

IMNN and

Correlation & Price change

A.I.dvisor tells us that IMNN and STOK have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMNN and STOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-4.76%
STOK - IMNN
30%
Poorly correlated
-4.55%
DNLI - IMNN
30%
Poorly correlated
-6.91%
PCSA - IMNN
30%
Poorly correlated
+4.17%
FGEN - IMNN
30%
Poorly correlated
-3.89%
DTIL - IMNN
29%
Poorly correlated
+0.43%
More